This CongresSpace publication summarizes the key topics discussed during the International Hyperhidrosis Networking Dinner held in conjunction with the EADV Congress 2024 in Amsterdam, focusing on recent clinical evidence and therapeutic strategies for the management of hyperhidrosis. The contributions address primary hyperhidrosis and its impact on quality of life, examining the evolution of therapeutic approaches…

This publication presents a multidisciplinary experience of dietary and nutritional treatment in advanced chronic kidney disease through the clinical journey and personal narrative of Merita, a patient who followed a low-protein diet for several years and subsequently a very-low-protein diet supplemented with ketoanalogues. The volume reconstructs the patient’s nephrological and nutritional journey, illustrating the role…

This publication from the MedSpace – Hematology series explores the management of patients with high-risk acute myeloid leukemia treated with CPX-351, a liposomal formulation of cytarabine and daunorubicin, through a collection of Italian clinical experiences and an analysis of the organizational and pharmacoeconomic aspects of treatment. The case reports describe the use of CPX-351 during…

The volume presents real-world experiences with biosimilar adalimumab in the management of chronic inflammatory diseases affecting the skin, joints and intestine. Through clinical cases from dermatology, gastroenterology and rheumatology, it explores treatment effectiveness and safety as well as the clinical implications of switching between biological and biosimilar therapies. The cases focus on chronic plaque psoriasis,…

This publication explores the pharmacological aspects and clinical evidence of self-occlusive topical anesthesia in dermatology and aesthetic medicine, with particular reference to the combination of 7% lidocaine and 7% tetracaine. It examines the mechanism of action of local anesthetics, the characteristics of eutectic mixtures and the advantages of self-occlusive formulations, together with the main clinical…

The volume examines the use of Vyxeos® liposomal (CPX-351) in the treatment of high-risk acute myeloid leukemia, with particular reference to therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Using a Health Technology Assessment approach, it evaluates the clinical and pharmacoeconomic evidence for Vyxeos® liposomal compared with the standard 7+3 regimen, considering survival, life-years…

The volume presents a series of clinical observations on the use of dimethyl fumarate (DMF) in patients with different forms of moderate-to-severe psoriasis. Through cases from clinical practice, it explores treatment response, dose adjustment, tolerability and the impact of therapy on patients’ quality of life. The clinical experiences include plaque psoriasis, involvement of sensitive areas…